This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nebert DW, Menon AG . The Pharmacogenomics Journal 2001 1: 19–22
Kalow W, Bertilsson L . Advanc Drug Res 1994 23: 1–53
Kalow W . Arch Pathol Lab Med 2000 125: 77–80
Kalow W . Drug Metab Disp 2001 29: 468–470
Acknowledgements
We thank Dr Laszlo Endrenyi for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalow, W., Ozdemir, V. & Tothfalusi, L. Multigenic traits and risk assessment in pharmacology: a population approach. Pharmacogenomics J 1, 234–235 (2001). https://doi.org/10.1038/sj.tpj.6500061
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500061
This article is cited by
-
Reply to Kalow et al
The Pharmacogenomics Journal (2001)